000 | 01740 a2200469 4500 | ||
---|---|---|---|
005 | 20250517232819.0 | ||
264 | 0 | _c20200127 | |
008 | 202001s 0 0 eng d | ||
022 | _a2173-5735 | ||
024 | 7 |
_a10.1016/j.otorri.2018.06.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRodríguez-Valiente, Antonio | |
245 | 0 | 0 |
_al-Thyroxine does not prevent immunemediated sensorineural hearing loss in autoimmune thyroid diseases. _h[electronic resource] |
260 |
_bActa otorrinolaringologica espanola _c |
||
300 |
_a229-234 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aAutoantibodies _ximmunology |
650 | 0 | 4 |
_aAutoantigens _ximmunology |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aEar, Inner _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHashimoto Disease _xcomplications |
650 | 0 | 4 |
_aHearing Loss, Bilateral _xetiology |
650 | 0 | 4 |
_aHearing Loss, Sensorineural _xetiology |
650 | 0 | 4 |
_aHearing Loss, Unilateral _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aSulfate Transporters _ximmunology |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _ximmunology |
650 | 0 | 4 |
_aThyroiditis, Autoimmune _xcomplications |
650 | 0 | 4 |
_aThyroxine _xtherapeutic use |
700 | 1 | _aÁlvarez-Montero, Óscar | |
700 | 1 | _aGórriz-Gil, Carmen | |
700 | 1 | _aGarcía-Berrocal, José Ramón | |
773 | 0 |
_tActa otorrinolaringologica espanola _gvol. 70 _gno. 4 _gp. 229-234 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.otorri.2018.06.001 _zAvailable from publisher's website |
999 |
_c28730085 _d28730085 |